المؤلفون: Stahl A; Department of Ophthalmology, University Medicine Greifswald, Greifswald, Germany., Sukgen EA; Department of Ophthalmology, Adana City Training and Research Hospital, Adana, Turkey., Wu WC; Department of Ophthalmology, Linkou Chang Gung Memorial Hospital, and College of Medicine, Chang Gung University, Taoyuan, Taiwan., Lepore D; Department of Geriatrics and Neuroscience, Catholic University of the Sacred Heart, A. Gemelli Foundation IRCSS, Rome, Italy., Nakanishi H; Research and Development Center for New Medical Frontiers, Department of Advanced Medicine, Division of Neonatal Intensive Care Medicine, Kitasato University School of Medicine, Sagamihara, Japan., Mazela J; Department of Neonatology, Poznan University of Medical Sciences, Poznan, Poland., Moshfeghi DM; Byers Eye Institute, Stanford University School of Medicine, Stanford, California., Vitti R; Regeneron Pharmaceuticals, Tarrytown, New York., Athanikar A; Regeneron Pharmaceuticals, Tarrytown, New York., Chu K; Regeneron Pharmaceuticals, Tarrytown, New York., Iveli P; Bayer AG, Wuppertal, Germany., Zhao F; Bayer Inc, Toronto, Ontario, Canada., Schmelter T; Bayer AG, Berlin, Germany., Leal S; Bayer Consumer Care AG, Basel, Switzerland., Köfüncü E; Bayer AG, Berlin, Germany., Azuma N; Department of Ophthalmology, National Center for Child Health and Development, Tokyo, Japan.

مؤلفون مشاركون: FIREFLEYE Study Group

المصدر: JAMA [JAMA] 2022 Jul 26; Vol. 328 (4), pp. 348-359.

نوع المنشور: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Angiogenesis Inhibitors*/administration & dosage , Angiogenesis Inhibitors*/adverse effects , Angiogenesis Inhibitors*/therapeutic use , Laser Coagulation*/adverse effects , Laser Coagulation*/methods , Receptors, Vascular Endothelial Growth Factor*/administration & dosage , Receptors, Vascular Endothelial Growth Factor*/therapeutic use , Recombinant Fusion Proteins*/administration & dosage , Recombinant Fusion Proteins*/adverse effects , Recombinant Fusion Proteins*/therapeutic use , Retinopathy of Prematurity*/drug therapy , Retinopathy of Prematurity*/surgery, Bevacizumab/therapeutic use ; Female ; Gestational Age ; Humans ; Infant ; Infant, Newborn ; Intravitreal Injections ; Male ; Treatment Outcome ; Vascular Endothelial Growth Factor A

المؤلفون: Wykoff CC; Retina Consultants of Houston, Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas. Electronic address: ccwmd@houstonretina.com., Shah C; Ophthalmic Consultants of Boston, Boston, Massachusetts., Dhoot D; California Retina Consultants, Santa Barbara, California., Coleman HR; Digital Angiography Reading Center (DARC), Great Neck, New York., Thompson D; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Du W; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Baker K; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Vitti R; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Berliner AJ; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Metzig C; Bayer HealthCare, Berlin, Germany., Saroj N; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.

المصدر: Ophthalmology [Ophthalmology] 2019 Aug; Vol. 126 (8), pp. 1171-1180. Date of Electronic Publication: 2019 Apr 01.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-4713 (Electronic) Linking ISSN: 01616420 NLM ISO Abbreviation: Ophthalmology Subsets: MEDLINE

مواضيع طبية MeSH: Laser Coagulation*/methods, Angiogenesis Inhibitors/*therapeutic use , Diabetic Retinopathy/*therapy , Macular Edema/*therapy , Receptors, Vascular Endothelial Growth Factor/*therapeutic use , Recombinant Fusion Proteins/*therapeutic use , Retinal Vessels/*physiology, Aged ; Double-Blind Method ; Female ; Humans ; Intravitreal Injections ; Longitudinal Studies ; Male ; Middle Aged ; Regional Blood Flow/physiology ; Vascular Endothelial Growth Factor A/antagonists & inhibitors

المؤلفون: Singh RP, Silva FQ, Gibson A, Thompson D, Vitti R, Berliner AJ, Saroj N

المصدر: Ophthalmic surgery, lasers & imaging retina [Ophthalmic Surg Lasers Imaging Retina] 2019 Mar 01; Vol. 50 (3), pp. 167-173.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Healio.com Country of Publication: United States NLM ID: 101599215 Publication Model: Print Cited Medium: Internet ISSN: 2325-8179 (Electronic) Linking ISSN: 23258160 NLM ISO Abbreviation: Ophthalmic Surg Lasers Imaging Retina Subsets: MEDLINE

مواضيع طبية MeSH: Angiogenesis Inhibitors/*therapeutic use , Diabetic Retinopathy/*drug therapy , Laser Coagulation/*methods , Macular Edema/*drug therapy , Receptors, Vascular Endothelial Growth Factor/*therapeutic use , Recombinant Fusion Proteins/*therapeutic use, Aged ; Aged, 80 and over ; Female ; Humans ; Intravitreal Injections ; Male ; Middle Aged ; Visual Acuity

المؤلفون: Dhoot DS; California Retina Consultants, Santa Barbara, California., Baker K; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Saroj N; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Vitti R; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Berliner AJ; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Metzig C; Bayer HealthCare, Berlin, Germany., Thompson D; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Singh RP; Cleveland Clinic Cole Eye Institute, Cleveland, Ohio. Electronic address: drrishisingh@gmail.com.

المصدر: Ophthalmology [Ophthalmology] 2018 Jan; Vol. 125 (1), pp. 51-56. Date of Electronic Publication: 2017 Jul 29.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-4713 (Electronic) Linking ISSN: 01616420 NLM ISO Abbreviation: Ophthalmology Subsets: MEDLINE

مواضيع طبية MeSH: Diabetic Retinopathy/*diagnosis , Laser Coagulation/*methods , Macular Edema/*therapy , Receptors, Vascular Endothelial Growth Factor/*administration & dosage , Recombinant Fusion Proteins/*administration & dosage, Aged ; Diabetic Retinopathy/complications ; Dose-Response Relationship, Drug ; Double-Blind Method ; Female ; Humans ; Intravitreal Injections ; Macular Edema/diagnosis ; Macular Edema/etiology ; Male ; Middle Aged ; Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors ; Retrospective Studies ; Risk Factors ; Severity of Illness Index ; Tomography, Optical Coherence ; Treatment Outcome

المؤلفون: Heier JS; Ophthalmic Consultants of Boston, Boston, Massachusetts., Korobelnik JF; Service d'ophtalmologie, CHU de Bordeaux, France; University Bordeaux, ISPED, F-33000 Bordeaux, Bordeaux, France; Inserm, U1219 - Bordeaux Population Health Research Center, F-33000 Bordeaux, France., Brown DM; Retina Consultants of Houston, Houston, Texas., Schmidt-Erfurth U; Medical University of Vienna, Vienna, Austria., Do DV; Ocular Imaging Research and Reading Center, Omaha, Nebraska., Midena E; Department of Ophthalmology, University of Padova, Padova, Italy., Boyer DS; Retina-Vitreous Associates Medical Group, Beverly Hills, California., Terasaki H; Nagoya University Hospital, Nagoya, Japan., Kaiser PK; Cole Eye Institute, Cleveland, Ohio., Marcus DM; Southeast Retina Center, Augusta, Georgia., Nguyen QD; Ocular Imaging Research and Reading Center, Omaha, Nebraska., Jaffe GJ; Department of Ophthalmology, Duke University, Durham, North Carolina., Slakter JS; Vitreous-Retina-Macula Consultants of New York, New York, New York., Simader C; Medical University of Vienna, Vienna, Austria., Soo Y; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Schmelter T; Bayer HealthCare, Berlin, Germany., Vitti R; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Berliner AJ; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Zeitz O; Bayer HealthCare, Berlin, Germany; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Metzig C; Bayer HealthCare, Berlin, Germany., Holz FG; Department of Ophthalmology, University of Bonn, Bonn, Germany. Electronic address: Frank.Holz@ukb.uni-bonn.de.

المصدر: Ophthalmology [Ophthalmology] 2016 Nov; Vol. 123 (11), pp. 2376-2385. Date of Electronic Publication: 2016 Sep 17.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-4713 (Electronic) Linking ISSN: 01616420 NLM ISO Abbreviation: Ophthalmology Subsets: MEDLINE

مواضيع طبية MeSH: Visual Acuity*, Diabetic Retinopathy/*therapy , Laser Coagulation/*methods , Macula Lutea/*pathology , Macular Edema/*therapy , Receptors, Vascular Endothelial Growth Factor/*administration & dosage , Recombinant Fusion Proteins/*administration & dosage, Aged ; Diabetic Retinopathy/complications ; Diabetic Retinopathy/diagnosis ; Double-Blind Method ; Female ; Fluorescein Angiography ; Follow-Up Studies ; Fundus Oculi ; Humans ; Intravitreal Injections ; Macular Edema/diagnosis ; Macular Edema/etiology ; Male ; Middle Aged ; Retinal Vessels/pathology ; Retrospective Studies ; Time Factors ; Tomography, Optical Coherence ; Treatment Outcome ; Vascular Endothelial Growth Factor A/antagonists & inhibitors

المؤلفون: Korobelnik JF; Service d'ophtalmologie, Hôpital Pellegrin-CHU de Bordeaux, Bordeaux, France; Université Bordeaux Segalen, Bordeaux, France; INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France., Do DV; Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska., Schmidt-Erfurth U; Medical University of Vienna, Vienna, Austria., Boyer DS; Retina-Vitreous Associates Medical Group, Beverly Hills, California., Holz FG; Department of Ophthalmology, University of Bonn, Bonn, Germany., Heier JS; Ophthalmic Consultants of Boston and Tufts University School of Medicine, Boston, Massachusetts., Midena E; Department of Ophthalmology, University of Padova, Padova, Italy., Kaiser PK; Cole Eye Institute, Cleveland, Ohio., Terasaki H; Nagoya University Hospital, Nagoya, Japan., Marcus DM; Southeast Retina Center, Augusta, Georgia., Nguyen QD; Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska., Jaffe GJ; Department of Ophthalmology, Duke University, Durham, North Carolina., Slakter JS; Vitreous-Retina-Macula Consultants of New York, New York, New York., Simader C; Medical University of Vienna, Vienna, Austria., Soo Y; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Schmelter T; Bayer HealthCare, Berlin, Germany., Yancopoulos GD; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Stahl N; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Vitti R; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Berliner AJ; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Zeitz O; Bayer HealthCare, Berlin, Germany; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Metzig C; Bayer HealthCare, Berlin, Germany., Brown DM; Retina Consultants of Houston, Houston, Texas. Electronic address: dmbmd@houstonretina.com.

المصدر: Ophthalmology [Ophthalmology] 2014 Nov; Vol. 121 (11), pp. 2247-54. Date of Electronic Publication: 2014 Jul 08.

نوع المنشور: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-4713 (Electronic) Linking ISSN: 01616420 NLM ISO Abbreviation: Ophthalmology Subsets: MEDLINE

مواضيع طبية MeSH: Laser Coagulation*, Angiogenesis Inhibitors/*therapeutic use , Diabetic Retinopathy/*drug therapy , Diabetic Retinopathy/*surgery , Macular Edema/*drug therapy , Macular Edema/*surgery , Receptors, Vascular Endothelial Growth Factor/*therapeutic use , Recombinant Fusion Proteins/*therapeutic use, Aged ; Angiogenesis Inhibitors/adverse effects ; Diabetes Mellitus, Type 1/complications ; Diabetes Mellitus, Type 2/complications ; Diabetic Retinopathy/physiopathology ; Double-Blind Method ; Female ; Humans ; Intravitreal Injections ; Macular Edema/physiopathology ; Male ; Middle Aged ; Receptors, Vascular Endothelial Growth Factor/adverse effects ; Recombinant Fusion Proteins/adverse effects ; Tomography, Optical Coherence ; Vascular Endothelial Growth Factor A/antagonists & inhibitors ; Visual Acuity/physiology

المؤلفون: Do DV; Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. ddo@jhmi.edu, Nguyen QD, Boyer D, Schmidt-Erfurth U, Brown DM, Vitti R, Berliner AJ, Gao B, Zeitz O, Ruckert R, Schmelter T, Sandbrink R, Heier JS

مؤلفون مشاركون: da Vinci Study Group

المصدر: Ophthalmology [Ophthalmology] 2012 Aug; Vol. 119 (8), pp. 1658-65. Date of Electronic Publication: 2012 Apr 24.

نوع المنشور: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-4713 (Electronic) Linking ISSN: 01616420 NLM ISO Abbreviation: Ophthalmology Subsets: MEDLINE

مواضيع طبية MeSH: Laser Coagulation*, Diabetic Retinopathy/*therapy , Macular Edema/*therapy , Recombinant Fusion Proteins/*administration & dosage, Diabetes Mellitus, Type 1/complications ; Diabetes Mellitus, Type 2/complications ; Diabetic Retinopathy/drug therapy ; Diabetic Retinopathy/physiopathology ; Diabetic Retinopathy/surgery ; Double-Blind Method ; Female ; Humans ; Macular Edema/drug therapy ; Macular Edema/physiopathology ; Macular Edema/surgery ; Male ; Middle Aged ; Receptors, Vascular Endothelial Growth Factor ; Recombinant Fusion Proteins/therapeutic use ; Retreatment ; Treatment Outcome ; Visual Acuity/physiology

المؤلفون: Do DV; Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University, Baltimore, Maryland, USA. ddo@jhmi.edu, Schmidt-Erfurth U, Gonzalez VH, Gordon CM, Tolentino M, Berliner AJ, Vitti R, Rückert R, Sandbrink R, Stein D, Yang K, Beckmann K, Heier JS

المصدر: Ophthalmology [Ophthalmology] 2011 Sep; Vol. 118 (9), pp. 1819-26. Date of Electronic Publication: 2011 May 05.

نوع المنشور: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-4713 (Electronic) Linking ISSN: 01616420 NLM ISO Abbreviation: Ophthalmology Subsets: MEDLINE

مواضيع طبية MeSH: Laser Coagulation*, Diabetic Retinopathy/*therapy , Macular Edema/*therapy , Recombinant Fusion Proteins/*administration & dosage, Diabetes Mellitus, Type 1/complications ; Diabetes Mellitus, Type 2/complications ; Diabetic Retinopathy/drug therapy ; Diabetic Retinopathy/physiopathology ; Diabetic Retinopathy/surgery ; Double-Blind Method ; Female ; Humans ; Intravitreal Injections ; Macular Edema/drug therapy ; Macular Edema/physiopathology ; Macular Edema/surgery ; Male ; Middle Aged ; Receptors, Vascular Endothelial Growth Factor ; Recombinant Fusion Proteins/adverse effects ; Retina/pathology ; Retreatment ; Tomography, Optical Coherence ; Treatment Outcome ; Visual Acuity/physiology